MetLife Investment Management’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Buy |
79,316
+27,874
| +54% | +$58.3K | ﹤0.01% | 2283 |
|
|
2025
Q1 | $87.7K | Buy |
51,442
+6,482
| +14% | +$11.1K | ﹤0.01% | 2584 |
|
|
2024
Q4 | $227K | Sell |
44,960
-7,335
| -14% | -$37K | ﹤0.01% | 2242 |
|
|
2024
Q3 | $284K | Hold |
52,295
| – | – | ﹤0.01% | 2095 |
|
|
2024
Q2 | $251K | Buy |
52,295
+18,301
| +54% | +$87.8K | ﹤0.01% | 2109 |
|
|
2024
Q1 | $106K | Sell |
33,994
-934
| -3% | -$2.91K | ﹤0.01% | 2506 |
|
|
2023
Q4 | $99.2K | Hold |
34,928
| – | – | ﹤0.01% | 2610 |
|
|
2023
Q3 | $102K | Hold |
34,928
| – | – | ﹤0.01% | 2563 |
|
|
2023
Q2 | $99.9K | Hold |
34,928
| – | – | ﹤0.01% | 2683 |
|
|
2023
Q1 | $108K | Hold |
34,928
| – | – | ﹤0.01% | 2514 |
|
|
2022
Q4 | $73.7K | Buy |
+34,928
| New | +$73.7K | ﹤0.01% | 2691 |
|